Print Page   |   Sign In   |   Join ISSX
ISSX News: General

ISSX Biotransformation, Mechanisms, and Pathways Focus Group July 2020 Newsletter

Thursday, July 16, 2020   (0 Comments)
Posted by: ISSX
Share |

The ISSX Biotransformation, Mechanisms, and Pathways Focus Group (BMPFG) is chaired by Amit Kalgutkar of Pfizer Inc and co-chaired by Valerie Kramlinger of Novartis Institute for Biomedical Research. The goals of this group are to disseminate and promote state-of-the-art research and foster discussion and collaboration among ISSX members on the role of biotransformation in drug design, drug-drug interactions, drug safety, and beyond. In addition to providing a discussion forum, this group will also aim to generate and publish position papers on new vistas in biotransformation science in relation to drug discovery/development. The focus group will engage members throughout the year via webinars, workshops, and by contributing to ISSX meeting planning.

Read the July 2020 ISSX BMPFG Newsletter.

Join the ISSX BMPFG.

Join the ISSX BMPFG conversation on LinkedIn!

Register for these upcoming ISSX BMPFG Webinars:

  • July 17: Biotransformation in the Context of Drug Design: Steps Taken to Enhance Drug Properties 
    Presented by Dr Cyrus Khojasteh, Genentech
    Register Now
  • September 21: Ozanimod Metabolism – Qualification of Disproportionate Metabolites 
    Presented by Dr. Sekhar Surapaneni, BMS
    Register Now

Association Management Software Powered by YourMembership  ::  Legal